MIP PHARMA POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

TAX ID5262627553

KRS0000044185

Share capital50,000.00 zł

★ ★ ★ ★ ★ ★ ★ ★ ★ ★

No opinion. Add your first review

address

UL. ORZECHOWA 5, 80-175 GDAŃSK

Show on map

Is this your company?Update company information to get new customers, get notified of new reviews, and more!

Register Data

Full name

MIP PHARMA POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

uses securityreCAPTCHA

Privacy – Terms of Use

Legal address

UL. ORZECHOWA 5, 80-175 GDAŃSK

Show on map

NIP

5262627553

REGON

017362550

KRS

0000044185

Legal form

limited liability company

Register Address

UL. ORZECHOWA 5, 80-175 GDAŃSK

Date of registration in KRS

2001-09-17

Date of commencement of economic activity

2001-09-17

Act signature

GD.VII NS-REJ.KRS/20324/20/565/ADE

Pkd codes

46.46.Z - Wholesale trade of pharmaceutical and medical products

21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products

47.74.Z - Retail sale of medical and orthopedic products

47.75.Z - Retail sale of cosmetics and toiletries

72.20.Z - Scientific research and development in social sciences and humanities

73.11.Z - Advertising agency activities

73.20.Z - Market research and public opinion polling

74.90.Z - Other professional, scientific and technical activities, not elsewhere classified

85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms

96.09.Z - Individual service activities

Payer VAT status

Active

Vat list bank account(s)

PL13 2490 0005 0000 4600 0010 8929

PL22 2490 0005 0000 4600 9046 6983

PL67 2490 0005 0000 4600 7737 5635

PL06 2490 0005 0000 4530 8200 4938

PL24 1090 2851 0000 0001 4208 1011

PL30 1090 1043 0000 0000 0510 6682

Show more bank accounts from VAT list (3)

Company authorities

representation authorityMANAGEMENT

representation type

KAŻDY CZŁONEK ZARZĄDU SAMODZIELNIE

MANAGEMENT

Barbara Wanda Balkowska

Vice President, 64 years old

Friedrich Sernetz

Chairman Of The Board

shareholders

MIP PHARMA GMBH

100% 100 udziałów o łącznej wartości 50.000 zł

Financial data

Net sales [PLN]

Gross profit / loss [PLN]

Automatically generated based on financial statements from KRS Registry

	2022	2023	2024
	M PLN	M PLN	M PLN	%
Gross profit (loss)	14	13,9	12	-13,2
EBITDA	14,1	14,8	12,5	-16
Short time liabilities	3,3	1,9	1,7	-11,8
Equity capital	25,4	34,6	42,3	22,2
Operating profit (EBIT)	13,6	14,1	11,4	-18,8
Assets	29,2	37	45,1	21,8
Net profit (loss)	11,2	11,2	9,7	-13,5
Cash	4,5	6,5	3,5	-45,2
Liabilities and provisions for liabilities	3,8	2,4	2,8	16,7
Net income from sale	62,8	70,2	63,9	-8,9
Working assets	17,2	19,5	13,5	-31
Depreciation	0,5	0,7	1	38,1
	%	%	%	p.p.
Profitability of capital	44,1	32,3	22,9	-9,4
Equity capital to total assets	87,1	93,6	93,9	0,3
Gross profit margin	22,2	19,8	18,8	-1
EBITDA Margin	22,4	21,1	19,5	-1,6
	Days	Days	Days	Days
Short term commitment turnover cycle	19	10	10	0

Current financial liquidity indicator				-2,4
Net dept to EBITDA				0,6